Objective: To review publications about the main features of post-infectious bronchiolitis obliterans and its history, etiology, epidemiology, risk factors, pathogenesis, histological findings, clinical presentation, complementary tests, diagnostic criteria, differential diagnosis, treatment and prognosis.
Introduction
Bronchiolitis obliterans (BO) is a clinical syndrome characterized by the chronic obstruction of small airways that, by definition, are less than 2 mm in diameter. 1, 2 Several causes of BO have been described, such as infections caused by viruses, atypical germs or bacteria, foreign body or gastric content aspiration, inhalation of toxins, collagenosis, or lung or bone marrow transplant. The purpose of this review was to describe the several aspects associated with post-infectious bronchiolitis obliterans (PIBO), the most common form of BO in children. 3 
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History
The term "bronchiolitis obliterans" was first used in 1835, and then again only in 1901 for two patients with chronic cough and dyspnea of undetermined origin who later died. 4, 5 In 1953, Swyer & James described the case of a 6 year old boy with unilateral pulmonary hyperlucency, reduced lung volume and ipsilateral reduction of pulmonary artery caliber. 6 In 1954, MacLeod described this syndrome in nine adult patients that had unilateral pulmonary hyperlucency. 7 Today, the Swyer-James or MacLeod syndrome is one of the presentations of PIBO.
Since the end of the 1980s, after the description of new etiologic factors and the advent of high resolution CT (HRCT), which provides detailed images of the small airways, the interest in BO has been growing, and the number of publications about it has multiplied. During this time, particularly in Latin America, outbreaks of adenovirus infection have been detected, and patients that developed PIBO had been previously affected by that infection.
Etiology
BO is a final process common to several lung injuries.
However, in 1/3 of the cases, the cause is unknown. 8 Most studies associate PIBO with adenovirus infections, although other viruses may also be implicated: measles, influenza, parainfluenza, and respiratory syncytial virus (RSV).
Adenovirus has already been identified as a cause of PIBO in up to 72% 9 of the cases; in different study populations, about 30 3 to 60% 10 of the cases of adenovirus infection progress into PIBO. Serotypes 3, 11 7, 3,12 11 13 and 21 14, 15 have been described as the most virulent.
Questions have been raised about RSV infection being a possible cause of PIBO because, although it is the agent most often associated with acute viral bronchiolitis (AVB), there are few reports in the literature of PIBO secondary to RSV infection. 5, 8 However, this virus has been detected in patients that develop PIBO in up to 30% of the cases. 10 The occurrence of simultaneous infection by adenovirus and RSV has been associated with the worst outcomes. 16, 17 Coinfection of viruses and bacteria may be associated with greater risk of lung lesions. 3 PIBO has also been described as a consequence of infection by bacteria, such as Staphylococcus aureus 18 and Streptococcus pneumoniae, 19 or atypical germs, such as Mycoplasma pneumoniae. 20 Mycoplasma infection, in some cohorts, was the second most frequent etiologic agent and explained about 26% of the cases. 19, 21 
Epidemiology
No epidemiological data about PIBO have been produced so far, but there seems to be a predominance of cases in the southern hemisphere (Argentina, Brazil, Chile, and New Zealand) and a lower frequency in the United States and Europe. 5 corroborates this hypothesis.
At the same time, reports delivered during recent scientific meetings in several centers with a tradition in the care of PIBO suggest a reduction in the incidence of the disease in the last few years, probably due to the decrease in microepidemic outbreaks of severe adenovirus infection. 27 
Risk factors
It remains unclear why some children develop PIBO after AVB. Viral load, immunological response and genetic and environmental factors may be associated. 9 Some possible risk factors for the occurrence of PIBO have been described: adenovirus AVB (odds ratio [OR] = 49.9), 9 hospitalization for longer than 30 days (OR = 27.2), 3 multifocal pneumonia (OR = 26.6), 3 need of mechanical ventilation (OR = 11.9), 9 and hypercapnia (OR = 5.6). 3 In an isolated study, elevated IgE levels were thought to be associated with a worse prognosis, 28 but this finding was not reported in any of the studies with larger cohorts. The analysis of mechanical ventilation changes did not clarify whether it is an indicator of disease severity or the factor responsible for, even if only partially, the direct induction of airway lesions. 9 Data about the age at the time of event are controversial.
In children with adenovirus pneumonia, the younger the child at the time of pneumonia, the greater the risk of having an abnormal pulmonary function tests later on. 12 A B
However, a study found that children with PIBO who remained symptomatic had pulmonary lesions at more advanced ages than the children that became asymptomatic during followup (mean 5 and 2 months, respectively). 29 Bilateral pulmonary involvement is expected in cases of PIBO and is associated with greater severity. A study has found that children with bilateral pulmonary involvement had higher risks of persistent respiratory symptoms, recurrent pneumonia episodes, malnutrition and digital clubbing than children with unilateral involvement. 19 
Pathogenesis
Despite the diversity of microorganisms involved in the etiology of PIBO, all share the capacity to affect epithelial cells of the respiratory tract during the acute phase. The lesions lead to necrosis of bronchiolar epithelial cells and peribronchial, intraepithelial, and interstitial inflammatory infiltrate. 30 The specific role of each cell in the pathogenesis of PIBO is not fully understood. A study to determine the lymphohistiocytic profile using fragments of pulmonary biopsy tissue of patients with PIBO have found that the CD3+T cells were the most frequently found and that there was a predominance of the CD8+T cell subtype. CD8 cells may lead alveolar epithelial cells to produce cytokines, which intensify inflammation and perpetuate lung lesions. 30 Immunocomplexes containing the virus have been found in the lung of patients with adenovirus penumonia. 5, 8, 31 Moreover, the increases of IL-6, IL-8 and TNF-α have been associated with greater severity of adenovirus infection. 32 In the bronchoalveolar lavage (BAL) fluid of patients with PIBO, the percentage of neutrophils ( Figure 1 ) is elevated, and there is a discrete increase of lymphocytes, as well as an increase in IL-8 concentrations, a chemokine for neutrophils. 33 These findings were confirmed years after pulmonary insult, which suggests that inflammation is persistent. 34 The development of animal BO models may contribute to a better understanding of its pathogenic mechanisms and facilitate the study of possible treatment regimes. An experimental model, developed using the intratracheal instillation of nitric acid in rats and inducing histological changes compatible with constrictive BO, may be adapted for use in future experimental studies. 35 
Histological changes
Histological findings are similar, regardless of etiology, which suggests that BO corresponds to a final response to different insults to the epithelial cells of the small airways, which advances by means of intraluminal healing instead of the normal repair path. 5, 8 There are two histologically well defined types if BO:
constrictive bronchiolitis and proliferative bronchiolitis. The latter is characterized by granulation tissue in the form of a polypoid mass inside the airway. When the granulation tissue is also found inside the alveoli, the patient has bronchiolitis obliterans organized pneumonia (BOOP), 36 currently called cryptogenic organizing pneumonia, 8 which is not found in PIBO.
Most patients with PIBO have the constrictive form, which was identified in up to 97% of the cases. 36 Total obliteration of bronchioles starts with the necrosis of bronchiolar epithelium and inflammatory infiltration of the mucosa, submucosa, peribronchiolitis area, and the bronchiolar lumen, predominantly in terminal bronchioles.
Adjacent pulmonary parenchyma is spared or has very little involvement. Bronchioles often lose their form and have collagen deposition and mucous buffers. In a more advanced stage, there is submucosal fibrosis, which reaches the bronchiolar lumen in a concentric pattern. As fibrosis advances, the bronchiolar lumen reduces progressively to the point of full obliteration. 37 Indirect signs of airway obstruction may be seen, such as mucostasis, macrophage accumulation, hyperinflation, bronchiolar distortion and dilatation. 5, 36 In addition to the changes in the small airways, changes in larger airways may also be seen. There may be hypertrophy or thickening of the bronchial epithelium, and sometimes the lumen of larger bronchi may be occluded, which may lead to BO. 8, 20 Clinical presentation
The diagnosis of PIBO should always be suspected in previously healthy children that develop chronic respiratory symptoms for longer than 4 to 8 weeks after an episode of acute, usually severe infection. [8] [9] [10] [36] [37] [38] [39] The clinical presentation of PIBO is unspecific and both the severity and extension of bronchopulmonary lesions vary widely, which may contribute to the fact that they may be underdiagnosed. Despite possible ethnic or geographic differences, a study with Korean and American patients reported that clinical, radiological, and functional findings were similar in the two countries. 40 The persistence of symptoms, such as tachypnea, wheezing, and productive cough, is usually the first noticeable sign. Several of these patients are followed up for several years with a diagnosis of asthma, but the unsatisfactory response to oral or inhaled corticoids and oral or inhaled bronchodilators draws the attention to the possibility of another diagnosis. 19 The presence of crackles during follow-up is a remarkable change seen during physical examination of most patients. 18, 19, 28 PIBO should also be suspected in case of chronic coughing or expectoration, decreased vesicular murmur, recurrent pneumonia, impaired weight and height gains and episodes of hypoxemia and desaturation secondary to physical exercise or during sleep. 37 Low arterial oxygen saturation may indicate severity, and hypoxemia has been described in up to half of the patients. 40 In more severe cases, there might be thorax deformity, digital clubbing, and signs and symptoms of pulmonary arterial hypertension (PAH). 17, 18, 41 Although the Swyer-James or MacLeod syndrome may be within the PIBO spectrum, no studies have differentiated it from typical forms of PIBO. However, the clinical presentation of this syndrome seems to be milder (Fischer GB, personal communication).
Radiography and laboratory tests

Chest X ray
Ideally, a simple inspiration-expiration chest X ray should be requested. Changes are unspecific, but they may contribute to rule out diseases that are part of the differential diagnosis.
During AVB, there is hyperinflation, interstitial infiltrate, peribronchial thickening, areas of segmental or subsegmental atelectasis and consolidations. 18, 28, 38 Parenchymatous lesions tend to be severe and extensive, particularly when the etiologic agent is adenovirus. 15 After the initial episode, pulmonary hyperinflation may persist, as well as air trapping, which may be generalized or localized in one lung. Uni-or bilateral hyperlucency may be a consistent finding, 21,28,40 already described in up to 50% of the cases. 19 Persistent atelectasis has been found in up to 30% of the cases. 18 Although not the best test to evaluate bronchiectasis, a chest X ray may be used to detect it in some patients. 28 Sometimes, cardiomegaly and indirect signs of pulmonary hypertension may also be found. 37 However, chest X ray changes are usually poor when compared with clinical signs and symptoms and CT findings, and it may be normal in some cases. 19 A study has described the five most frequent patterns of PIBO 21 : 1) unilateral hyperlucency and increased lung volume; 2) persistent atelectasis in one or more lobes;
3) Swyer-James or MacLeod syndrome (hyperlucent lung and normal or decreased lung volume) 6,7 ; 4) bilaterally hyperlucency; 5) mixed pattern of hyperlucency, persistent atelectasis and peribronchial thickening. The latter pattern was the most frequent in that study. 21
High-resolution CT
There is a consensus that the diagnosis of PIBO may be made at a good safety margin when clinical findings and noninvasive tests are analyzed. 5, 18, 19, 21, 29 There is no specific finding for PIBO, but, when correlated with the clinical presentation, chest HRCT is the best exam to diagnose PIBO. HRCT provides information about bronchial lesions or lesions of the small airways 21 because it is more sensitive than chest X rays and pulmonary scintigraphy to detect airway and parenchyma abnormalities that occur during PIBO.
HRCT findings may be divided into direct and indirect. 42 Direct signs are wall thickening and bronchiole obliteration, but they are less frequent. 43 Indirect signs include bronchiectasis, bronchial wall thickening, mosaic perfusion, air trapping, decreased lung volume, and reduced hilar and peripheral vessel diameters. 29 The most frequent signs in several studies were mosaic perfusion, air trapping, vascular attenuation, bronchiectasis and peribronchial thickening ( Figure 2 and Table 1 ). The data about the frequency of CT abnormalities in patients of eight centers are seen in Table 1 .
The comparison of inspiration and expiration images provides the chance to combine structural and functional information and evaluate the presence of air trapping and hypoxic vasoconstriction, which may appear as areas of mixed hypo-and hyperattenuation (mosaic perfusion). 44 This finding is probably one of the most sensitive markers of PIBO, but it is not very specific because it is found in other pathologies, such as vascular and infiltrative diseases of the lung parenchyma. 45 In about 13 to 18% of the cases, inspiration images are normal, and attenuation heterogeneity is only seen during expiration. 46 The identification of air trapping in the expiration sections may also be useful to differentiate the airway diseases from other causes of mosaic perfusion. 42 Few studies have evaluated lesion extension using HRCT.
In one of them, about 64% of the patients had bilateral abnormalities associated with poorer clinical progressions. 19 In another series, involvement was bilateral in all cases, and air trapping was diffuse in 55% of the cases and multifocal in 45%. Those authors found no direct signs of bronchiolar lesions in the CT scans under analysis. 29 In another study that used densitometry and volumetry, a CT technique that uses three-dimensional reconstructions of lung parenchyma to measure the volume of lung parenchyma with normal and abnormal (non-functional) densities, found an inverse correlation with functional tests (FEV 1 ) and oxygen saturation during the 6-minute walk test. 47 The CT differential diagnosis between severe persistent asthma and BO remains challenging. A study compared CT findings of adult patients with severe asthma or BO of several etiologies and diagnosis confirmed by lung biopsy, and found that only mosaic perfusion was statistically significant to differentiate the two diseases (p = 0.0006).
Mosaic perfusion was significantly larger in patients with BO, but was found in only one patient with asthma and in a small area of the lung. 48 The pulmonary function tests tend to differentiate the two conditions because the pattern of fixed obstruction in PIBO is the opposite in patients that have asthma with reversible obstruction.
The main limitations of CT are the exposure to radiation and the difficulty to obtain quality images in small children, which requires, in many cases, sedation or general anesthesia with endotracheal intubation. Protocols with low radiation doses have been used without any substantial harm to image quality and should always be taken into consideration when using CT for infants or children. 49 The lateral decubitus technique has been described as an alternative for the expiration technique in small children. 50
Ventilation-perfusion scintigraphy
Changes are also unspecific, but scintigraphy provides valuable information, particularly for the evaluation of extension, distribution, and severity of lung involvement.
In most patients, there is a heterogeneous distribution of technetium-99m in the lung parenchyma, as in ventilationperfusion scintigraphy. Zhang et al. found perfusion abnormalities in all patients with BO in their study. 28 The comparison of lung perfusion with chest X ray reveals that scintigraphy changes correspond to the most affected areas in the radiographs, with peribronchial thickening and bronchiectasis. 5 Patients with more perfusion defects in scintigraphy also tend to have greater morbidity, and the extension of perfusion defects is associated with the 
Pulmonary function tests
The typical PIBO pattern is a fixed obstructive ventilation disorder whose severity is variable with a marked reduction of terminal flows, particularly the forced expiratory flow between 25 and 75% (FEF 25-75% ). Its marked decrease (< 30%) is a sensitive indicator of PIBO in infants and children with a compatible clinical presentation. 21 In PIBO, the involvement of small airways is more severe than in other diseases, such as asthma and bronchopulmonary dysplasia. 5 Spirometric indices vary substantially between studies (Table 2) , and this difference may be associated with the differences of each population and the severity of the disease. Expiration curves show a marked concavity (Figure 3) , and there might be a reduction in forced vital capacity (FVC) associated with air trapping. 44 Plethysmography showed that most patients had normal total lung capacity (TLC). 44 However, it might be increased in some cases, 5, 8 and there might be an increased residual volume (RV) and RV/TLC ratio. 34 When the forced oscillation technique was used, patients with PIBO had a more marked increase in air resistance than patients that also had adenovirus pneumonia but did not develop PIBO. 41 The obstructive pattern is found at an early stage in PIBO. Functional studies with infants revealed that forced expiratory maneuvers had a marked effect on the curve and reduced expiratory flows, particular tidal expiratory flows. 53 Moreover, there was a decrease of compliance and an increase of airway resistance. 53 The evaluation of pulmonary function in infants is not available in all centers. There is evidence that CT changes in children younger than 3 years may predict future pulmonary function. 54 Some patients have a positive response to intermittent bronchodilators, although marked obstruction persists. 21, 40 Whenever it occurs, bronchial hyperresponsiveness differs from that seen in patients with asthma. Most patients with PIBO are hyperresponsive to methacholine, but not to adenosine 5-monophosphate, whereas patients with asthma usually respond to the two substances. 55 Children with PIBO who underwent cardiopulmonary exercise tests and the 6-minute walk test had a reduced exercise capacity in both. In the 6-minute walk test, there was a reduction in distance walked, a fall in oxygen saturation, and an increased sensation of dyspnea. 56, 57 This test is easily applied and is useful as a screening tool, particularly where the cardiopulmonary test is not available. 27 There is some controversy among authors in relation to findings of pulmonary function in children with PIBO. Some believe that children with mild or moderate ventilation disorders should not be diagnosed with PIBO, and most authors believe that the degree of response to bronchodilator is variable, but does not achieve full reversibility because airway obstruction is fixed. 10 
Lung biopsy
Histological examination of an adequate fragment obtained by lung biopsy remains the most accurate method to diagnose PIBO. 38 Open lung biopsy 18, 28, 40 may be obtained by removing a fragment from the lingula or the area believed to be more severely affected.
Although lung biopsy establishes the diagnosis of PIBO, the lesions are distributed heterogeneously; therefore, tissue that has not been affected may be harvested. The absence of characteristic changes in the fragment analyzed does not rule out the diagnosis of PIBO. 37 According to reports, biopsies may not diagnose PIBO in up to 30% of the cases.
The changes found may be mild, depending on the disease stage and the region from where the fragment was collected. In initial stages, bronchiolar epithelial necrosis and inflammation may be found, but fibroblastic response may still be at a minimal stage. 18 When more advanced, lung tissue may be destroyed, which may complicate the identification of bronchioles. 18 Small changes that may suggest airway obstruction should, therefore, be taken into consideration.
Currently, considering the limitations described above and the risks of the procedure, the need to perform lung biopsies to establish the diagnosis of PIBO has been questioned. 18, 21, 28, 38 With the advent of HRCT, the method of choice to evaluate small airways, 22 lung biopsy has been used only in selected cases for which HRCT findings are not available or are inconclusive. 21 Most diagnoses in the differential analysis may be excluded using noninvasive examination. However, in cases of severe progression and gradual deterioration in spite of treatment, a biopsy may be useful to confirm the diagnosis 22 ( Figure 4 ). A study with 125 Argentinean children younger than 2 years used a score to predict PIBO based on the following variables: typical clinical history (4 points), adenovirus infections (3 points), and HRCT scan with mosaic perfusion (4 points). A score ≥ 7 may predict a diagnosis of PIBO with a specificity of 100% and sensitivity of 67%. Their study, however, included only patients with a severe form of the disease. 39 The search for more accurate criteria to diagnose PIBO is important, but if these criteria are not met, the adoption of support measures should not be delayed because they may improve prognosis and the quality of life of these patients.
Cardiovascular evaluation
Numerous patients are referred to specialized centers only at a late stage. A study conducted in the pediatric Pulmonology unit of Hospital de Clínicas of UFMG followed up 23 children for a mean time of 6 years (maximum = 19 years), and found that, although the pulmonary insult occurred before 12 months of age in 69% of the cases and the patients had persistent symptoms after that initial insult, mean age at diagnosis was 5.7 years (p<0.001).
Most patients were referred to the pediatric Pulmonology outpatient service of UFMG with a diagnosis of asthma or recurrent pneumonia. 58 
Differential diagnosis
To establish the diagnosis of PIBO, other pulmonary diseases should be ruled out, particularly those that To define the differential diagnosis of the Swyer-James or MacLeod syndrome, the following congenital malformations should be investigated: congenital absence of the pectoralis major muscle, congenital agenesis of pulmonary artery, and obstructive bronchial lesion. 24 Sequelae of viral infections may affect any individual, with or without a primary disease. Studies that investigate changes associated with PIBO should exclude patients with other diseases to avoid introducing a selection bias.
However, in clinical practice, a preterm infant or a child with another chronic disease may have AVB that leaves sequelae.
Therefore, PIBO should not be ruled out in children with other chronic diseases.
GERD does not exclude PIBO; in fact it may be secondary to PIBO because of the increased intraabdominal pressure resulting from lung hyperinflation. 44 A practical way to differentiate PIBO diagnosis in patients with AVB is that airway involvement is predominant in the acute phase, whereas in PIBO a severe case of pneumonia is associated (Fisher GB, personal communication). Patients should be treated by a multidisciplinary team that includes at least one pediatric pulmonologist, a pediatric cardiologist, a physical therapy specialist, a nutritionist, a psychologist, and a social worker. 57 Another study examined, in addition to nutrition, body composition, and found a low muscle mass reserve in 51% of the patients (33% had normal weight). 59 In addition, general preventive measures should be adopted, such as vaccination against pneumonia and influenza and a reduction in exposure to active or passive smoking. 37
Treatment
General support measures
Corticoids
Although frequently used in clinical practice, the use of corticoids to treat PIBO is controversial because no clinical trials have confirmed their efficacy so far. 28 Some authors recommend their use in the initial phases of the disease, before fibrosis is established. 8, 18 In a study that included 17 patients with BO, systemic corticoids were administered for at least 1 month, and 64.7% of the patients had clinical improvement, reduction of symptoms or increase in oxygen saturation. However, similar results were not repeated in other studies. 17, 18 There are reports of beneficial effects of pulse therapy with methylprednisolone (25 to 30 mg/day for 3 days) in the treatment of adenovirus AVB 60 and in children with PIBO. 37 In the latter case, oxygen saturation was normal 6 months after monthly administration of methylprednisolone. 40 However, studies are scarce and no clinical trial has evaluated the efficacy of pulse therapy in children with PIBO.
Bronchodilators
The use of β-adrenergic agonists is controversial and should be based on the positive response to bronchodilator during pulmonary function tests and on clinical criteria. 40, 44 About 25% of the patients are estimated to benefit from this treatment. Based on those results, some authors have recommended the use of azithromycin for PIBO, 8 although no studies have evaluated its efficacy in this group of patients.
Other drugs
As most evidence shows that PIBO is mediated by immunological mechanisms, treatment options have focused on reducing inflammatory responses. 5 In addition to corticoids, there are reports of the use of chloroquine and hydroxychloroquine 17,37 without satisfactory results.
However, the empirical monthly administration of IV immunoglobulin has been used as a treatment option in some cases. 8, 40 There is also a report of symptom improvement after the use of TNF-α monoclonal antibodies (infliximab) in children with BO after bone marrow transplants, 64 but no studies have included patients with PIBO so far.
Surgery and lung transplant
Surgical resection might have to be chosen for patients 
Prognosis
Studies with case series showed that PIBO progression is variable. In most cases, it seems to be chronic, nonprogressive, in contrast with BO after Stevens-Johnson syndrome or bone marrow transplant. 8 Most patients with PIBO tend to improve slowly and progressively. However, this clinical improvement may be associated with the growth of airways, and not necessarily resolution of inflammation. 22 Moreover, this improvement is partial for most patients, and they still have mild symptoms, particularly during physical exercise, and abnormal clinical findings. In a series of 31 children followed up for a mean time of 3.5 years, 9.7% of the patients died and 67.7% still had symptoms or clinical signs. 28 Morbidity associated with PIBO is high.
Recurrent wheezing was seen in 42% of the patients in another study, as well as bronchiectasis in 32% and chest deformities in 21%. 21 In another study, some patients developed chronic respiratory insufficiency and died. Different studies found mortality rates that range from 3.2 40 to 16.7%, 18 which may result from the differences in severity of the patients included in each study.
The progression of pulmonary function is unclear. The general prognosis of pulmonary function was poor in most publications. 5, 9, 28, 41 Most reports showed that spirometry of patients followed up for a long time had the same characteristics of fixed obstructive disease of moderate to severe severity without response to bronchodilators. A study that evaluated children with adenovirus pneumonia found that 65% had an obstructive pattern in their spirometry results after about 13 years. 12 Some reports reveal that the obstructive pattern is maintained the same along time, 28 but there is also a slow and progressive fall of spirometric values. 34 In a study with 11 children with PIBO, there was a fall of 1.02% per year in the FEV 1 /FVC, of 1.01% per year in FEV 1 and of 1.04% per year in FEF 25-75% . 34 According to some authors, inflammation persists after the acute airway lesion, which might explain the persistence of symptoms, 28 the recurrence of radiological changes, 29 and the persistent changes in pulmonary function. 34 Although the first description of BO was made over one 
